Researchers from New York City-based NYU Langone Health have developed a genetic and lifestyle calculator that identifies people under age 50 who are most likely to develop colorectal cancer, the system said Jan. 27.
Oncology
Tampa, Fla.-based Moffitt Cancer Center has added Marcia Cross, actress and co-founder of the HPV Cancers Alliance, to its national board of advisers, the facility said Jan. 27.
NYU Langone's Perlmutter Cancer Center has appointed Faith Davies, MD, inaugural director of its Center for Blood Cancers, the system said this week.
More than 2 million middle and high school students said they used e-cigarettes last year, the American Lung Association found in its 20th annual State of Tobacco Control report.
Yale Cancer Center has appointed Mark Lemmon, PhD, as its deputy director, the facility said Jan. 25.
Boston-based Dana-Farber Cancer Institute named Scarborough, Maine-based New England Cancer Specialists its first affiliate member in Maine, the institute said Jan. 25.
Increasing diversity and accessibility to clinical trials is key to closing racial gaps in cancer care, Kathy Giusti and John Carpten, MD, wrote for The Hill Jan. 24.
Here are four cancer-related partnerships formed since Jan. 14.
The University of Chicago Medicine Comprehensive Cancer Center appointed Mary Dolan, PhD, its deputy director, the center said Jan. 19.
The University of Texas MD Anderson Cancer Center in Houston and Planegg, Germany-based Eisbach Bio GmbH announced a research collaboration on Jan. 19 dedicated to discovering and developing precision oncology drugs that target synthetic lethal engines.